This study aims to examine the effect of cash turnover, receivable turnover, inventory turnover, cash conversion cycle, and fixed asset turnover on profitability (ROA) in pharmaceutical subsector companies listed on the Indonesia Stock Exchange (IDX) from 2020 to 2024. The research seeks to understand how working capital efficiency and asset utilization contribute to improving a company’s financial performance, particularly in generating profits.A quantitative approach was applied using secondary data derived from the annual financial statements of pharmaceutical companies. The sample, selected through purposive sampling, consists of 13 companies with a total of 65 observations across five years. Data analysis involved descriptive statistics, classical assumption testing, and multiple linear regression using SPSS version 26 to evaluate the influence of each independent variable on profitability.The findings indicate that receivable turnover, inventory turnover, and the cash conversion cycle have a positive and significant effect on profitability. Meanwhile, cash turnover and fixed asset turnover show no significant influence. Simultaneously, all independent variables significantly affect profitability, with an R² value of 0.523, indicating that 52.3% of profitability variation is explained by the model. These results highlight that efficient management of receivables, inventory, and the cash conversion cycle plays a crucial role in enhancing profitability within the pharmaceutical sector.
Copyrights © 2026